Background: Several automated systems had been developed in order to reduce inter-observer variability in indirect immunofluorescence (IIF) interpretation. We aimed to evaluate the performance of a processing system in antinuclear antibodies (ANA) screening on HEp-2 cells.
INTRODUCTION
Antinuclear antibodies (ANA) are clinically useful markers of several chronic autoimmune diseases called connectivitis. Indirect immunofluorescence (IIF) which was described in 1958 has become the standard method for the detection of several autoantibodies including ANA [1] . In spite of the development of several assays like ELISA or microarrays, IIF on HEp-2 cells remains the "gold standard" for ANA screening [2] . Currently, there is no consensus on the potential *Address correspondence to this author at the Laboratory of Research in Immunology of Renal Transplantation and Immunopathology (LR03SP01), University Tunis El Manar, Charles Nicolle Hospital, Bd 9 Avril, 1006 Bab Saadoun, Tunis, Tunisia; Tel: +21698341791; Fax: +216 71561156; E-mail: gorgi.yousr@gmail.com factors that could influence IIF results (culture condition, fixative procedure of HEp-2 cells, starting dilution, antiglobuline specificity, etc.). In practice, most laboratories perform ANA screening at the 1/80 th dilution or less frequently at 1/160 th . It is worth to note that 10 to 15% of healthy adults has positive ANA at the 1/80 th titer and 5% at 1/160 th , and this frequency tends to increase with aging mostly in women after 60 years old. Obviously, positivity at these titers has no clinical significance.
The type and the localization of the fluorescence define the IIF pattern. The terminology of IIF images is not consensual, however the revised nomenclature made within the CANTOR project [1] would provide homogeneity in image definitions. This revised taxonomy outlines 6 groups of patterns: 1) Membranous nuclear patterns, 2) Nucleoplasmic patterns, 3) nucleolar patterns, 4) spindle apparatus patterns, 5) Cytoplasmic patterns and 6) negative [1] .
Besides, inter-laboratories and intra-laboratory discrepancies in terms of negative or positive aspects and in terms of pattern recognition depends on:
•
The variability inherent to the used kit of HEp-2 cells
• The reading system: microscope sensitivity, and the kind of the used lamp (HBO or LED)
• The threshold of positivity and the pattern identification, in fact usually several patterns overlap. Therefore, the skill of the observer is a key point.
Since the increase of ANA test requests, which led to speed up the reading time on microscope, the lack of standardization and inter-observer variability, several automated systems of image reading had been developed. These systems would be used in second reading after that of the human expert or within the framework of apprenticeship of the inexperienced juniors. Various stages are necessary: 1) the acquisition automated by the image, 2) a quality control of the image, 3) the segmentation of the image for the detection of the object, 4) the extraction of the characteristics to describe the object and the classification of the detected objects. The acquisition of a quality image depends on the automated tuning, on the adjustment of the intensity of the image, on the quality control of the sharpness and on the luminosity, on the detection of artifacts, on the real time evaluation of the aspect of fluorescence and on the calibration of the fluorescence. The advantage is to obtain comparable results between laboratories, which require a standardization of the IIF with a measure of the intensity in units of fluorescence and a calibrated system allowing in particular comparable studies of groups in various laboratories. The system has to allow, thanks to adapted software, the memorization of the acquired images and their archiving for possible comparisons.
Different systems are in development and, to our knowledges, those currently proposed for routine analysis with image interpretation are [3] :
• Aklides System (Medipan, Berlin, Germany) on HEp-2: negative / positive discrimination, 5 patterns The present study was undertaken to evaluate the performances of a new system, the CyclopusCADImmuno®, which is still undergoing a process of development and education.
MATERIAL AND METHODS

Patients and Controls
In this study, 64 ANA-positive sera from patients with a confirmed diagnosis of systemic lupus erythematosus (SLE) and 107 ANA-negative sera from healthy blood donors were included. The antigentargets of the collected ANA-positive sera were previously determined by both IIF on CrithidiaLucilae for the anti-dsDNA antibodies and immunodot (Innolia®) for the antibodies to extractable nuclear antigens (ENA). Sixty-three (98.4%) of the ANApositive sera contained at least 2 or more target specificities. ANA titers were considered high when it surpassed the 1/320 th dilution. Characteristics of the ANA-positive sera are recorded in Table 1 .
All patients and controls gave written informed consent to participate in the study, and patient anonymity was preserved using documents and methods approved by the local Ethics committee of Charles Nicolle Hospital.
Methods
Indirect Immunofluorescence (IIF) Assay
ANA detection was performed by IIF using 2 commercial kits of HEp-2 cells: BioSystems® and Euroimmun®. The complete incubation process was carried out manually: 1) first, the sera diluted at 1/80 th were incubated with HEp-2 cells for 30 minutes at room temperature, 2) Second, 3 washing of 5 minutes each with PBS-Tween, 3) third, incubation with goat antihuman IgG conjugated with fluorescein isothiocyanate and 4) fourth, after 3 washing, slides were embedded with a mounting medium. The ANA-negative sera were tested only in Euroimmun® HEp-2 kit.
Human Evaluation of ANA
Two skilled human experts whose experience in IIF analysis is about 18 and 9 years, respectively, evaluated the HEp-2 slides. Slides were interpreted within the Motic® BA310 Epi-LED FL microscope. The two experts worked blindly and independently without reference to each other or to the evaluated software's readings. The reported patterns were: 1) homogenous, 2) Speckled (fine speckled and/or coarse speckled), 3) nuclear dots, 4) nucleolar, 5) membranous nuclear, and 6) negative.
Automated Evaluation by the CyclopusCADImmuno®
The system used in this study is the CyclopusCADImmuno®(CAD), powered by CyclopusCADsrl, a spin-off of University of Palermo. It consists of an informatics program for image analysis using artificial intelligence. The CAD is connected to a high-resolution camera (AESKU® LED 3002), which is itself linked to the same fluorescence microscope used by human experts. The CAD system and the highresolution camera were acquired through the AIDA project funded under the European Cooperation ENPI Italy-Tunisia.
Statistical Analysis
The agreement between human and CAD pattern recognition was evaluated using statistics (SPSS 11 Inc. Chicago, Illinois, USA). Based on test, the agreement is poor when it ranges between 0 and 0.2, fair between 0.2 and 0.4, moderate between 0.4 and 0.6, substantial between 0.6 and 0.8, and almost perfect between 0.8 and 1. When is <0 the tests' results are considered contradictory. Analysis of the influence of ANA titers on discrepancies between human and CAD interpretations was performed using chi-square test or fisher's exact test for small numbers (SPSS 11 Inc. Chicago, Illinois, USA). Values of p < 0.05 were considered to be statistically significant.
RESULTS
In total, 64 ANA-positive sera and 107 ANAnegative sera were included in this study. Fifty (78.12%) sera had elevated titer of ANA and 63 (98.4%) had at least two or more target-antigen specificities ( Table 1 
Comparison between BioSystems and Euroimmun Patterns' Interpretation by Human Experts
Agreement between the two human experts was total (100%). Globally 23 (35.9%) sera were in a total agreement for the IIF patterns detected on the two tested HEp-2 kits. A partial agreement (sharing of one IIF pattern) was found in 28 (43.75%) cases while a complete disparity was observed in 13 (20.3%) sera. Besides, agreement was moderate for the most common IIF patterns, homogenous, speckled, nuclear dots and membranous nuclear; =0.43, =0.56, =0.488 and =0.435 respectively. Agreement between the two tested HEp-2 kits was not correlated to the titer of ANA.
Comparison between BioSystems and Euroimmun Patterns' Interpretation by CyclopusCAD
IIF patterns' identification was totally concordant in 17 (26.6%) sera, partly agreeing in 31 (48.5%) cases and completely disagreeing in only 16 (25%) samples. Agreement was poor for the homogenous and nucleolar patterns ( =0.143 and =0.124), fair for the nuclear dot pattern ( =0.333) and moderate for the speckled pattern ( =0.421). Again, the agreement between the generated patterns of the two kits was not associated to ANA titer.
Performance of the CyclopusCAD in Negative/Positive Discrimination
All ANA-positive sera of the lupus patients were recognized as positive, therefore its sensitivity is about 100%. By contrast, 17 (15.9%) of the ANA-negative sera were recognized as positive by the CyclopusCAD system, hence its specificity is about 84.1% ( Table 2) . The concordance between human expert and software interpretations was 90.05% and agreement was almost perfect, =0.8.It is worth to note that all of the 17 ANAnegative sera, which were identified by the CyclopusCAD as positive, had a cytoplasmic pattern. 
Performance of the CyclopusCAD in Identification of IIF Patterns on HEp-2 BioSystems®
Using human experts as reference, the CyclopusCAD identified the rightIIF pattern in 6 (9.37%) sera, while in 42 (65.6%) cases it recognized at least one of the mixed patterns. Inversely, in 16 (25%) ANA-positive sera, the CAD did not pinpoint the correct IIF pattern. Comprehensive analysis of the patterns showed ( Table 3) :
Moderate agreements for homogenous, speckled, and coarse speckled patterns 2) Incongruity for nuclear dots, nucleolar, membranous nuclear patterns Besides, discrepancies in IIF pattern identification were encountered more frequently in sera with low titers of ANA but differences failed to reach the threshold of significance.
Performance of the CyclopusCAD in Identification of IIF Patterns on HEp-2 Euroimmun®
The CyclopusCAD recognized the correct IIF pattern in five (7.8%) cases, whereas it pinpointed one of the patterns in 39 (60.9%) sera. However, the CAD system failed to determine the exact pattern in 20 (31.25%) cases. Detailed examination revealed ( Table  4) :
Moderate agreement for the coarse speckled pattern 2) Fair agreement for homogenous, speckled and fine speckled patterns
3)
Poor agreement for nuclear dots, nucleolar and membranous nuclear patterns Furthermore, agreement was non-significantly better in case of high titers of ANA.
DISCUSSION
In the present study, we enrolled 64 ANA-positive sera from lupus-diagnosed patients and 107 ANAnegative sera from healthy blood donors. The ANApositive sera were tested with both BioSystems® and Euroimmun® HEp-2 kits, while ANA-negative sera with Euroimmun® only. All images were interpreted independently by two human experts and by the system undergoing evaluation, the CyclopusCADImmuno®.
Comparative evaluation of the IIF patterns by human experts of the two tested HEp-2 kits revealed a concordance rate of 79.7% (35.9% complete agreement and 43.75% partial agreement). The best agreements involved specifically the most common IIF patterns, homogenous, speckled, nuclear dots and membranous nuclear. This results corroborates that the study of Copple et al. [4] , in which 5 HEp-2 kits (Kallestad®, ImmunoConcepts®, Zeus®, Euroimmun® and Inova®) were compared using 372 sera (50 SLE, 45 rheumatoid arthritis, 35 scleroderma, 20 Sjögren syndrome, 10 polymyositis, 12 reference sera from the CDC, 100 healthy blood donors and 100 sera from private laboratories). In this study, three skilled technologists made evaluation independently and blindly to sample classification and each other's reading [4] . Concordance between the 3 readers varied from 96% to 99% [4] . Overall, the percentage of agreement for the 5 HEp-2 assays was 78% and varied from 44% in the scleroderma sera to 93% in the healthy blood donor group [4] . Furthermore, the authors reported discrepancies in titers' estimation that reached for some specimens from to 1/80 th to 1/1280 th [4] . It has been proposed that the use of a polyconjugate versus an IgG-specific conjugate results in variability among the 5 tested kits. In fact, polyconjugate (G, A and M) or total IgG (heavy and light chain) leads to the detection of the IgM class of ANA associated with rheumatoid arthritis, medications, and ageing, which are usually clinically insignificant. Besides, other factors such as culture conditions, fixation procedures, pH, assay temperature and many others may cause variability in both generation IIF pattern and ANA titers [5] .
Evaluation of the CyclopusCAD performance in negative/positive discrimination revealed comparable characteristics with commercialized systems (Table 5 ) [3] . Besides, in the present study the 17 sera that were falsely considered as ANA-positive had a cytoplasmic pattern. In fact, such cytoplasmic fluorescence is able to be considered as a nucleoplasmic pattern if the segmentation of the nuclei is not perfect. In this regard, Tonti et al. [6] proposed a novel approach to the segmentation of HEp-2 cells relying on:
image acquisition 2) image enhancement Otherwise, comparative analysis of IIF patterns' interpretation between human experts and the CyclopusCAD revealed a good global concordance with either BioSystems® orEuroimmun®, 75% and 68.75% respectively. These overall performances are close to that of EuroPattern® system, which was estimated at 79% [3] . While, it may surpass those of the three other systems, Aklides® (52%), NovaView® (54%) and G-Sight® (63%) [3] . It is worth to note that in the comparative study of these commercialized systems used only single pattern sera [3] . In another study, including sera with mixed pattern, the global performance of the EuroPattern® system was estimated at 48.9% [7] . Therefore, recognizing mixed patterns is critical. Moreover, it has been reported in Aklides system [8, 9] , that distinction of patterns became problematic when there were 2 or 3 ANA specificities. Hence, considering the fact 98.4% of tested sera in our study had 2 or more specificities, the capacity of the CyclopusCAD, a system which is still ongoing licensing, is promising.
To improve performance of automated systems, including the CyclopusCAD, a greater number of images must be acquired using 2 or 3 dilutions in order to ease interpretation of mixed patterns. It is of note, that aside from G-sight system which was developed with HEp-2 and HEp-2000 (transfected with SSA antigen), all other systems are to be considered as closed. In fact, the automated systems recognize patterns only on the HEp-2 kit with which it had been licensed. Consequently, if reproducibility between laboratories using the same system would be satisfying, a certain variability will persist between those using different systems. Therefore, commercialized and ongoing development systems need to be educated on a wide range of different HEp-2 kits.
Besides, the big laboratories with a high debit of ANA requests tend to have a diagnostic approach in 2 stages. A first stage of positive/negative screening then a second stage of titration via serial dilutions. A calibration of the automated system according to the intensity of the fluorescence would allow obtaining straightaway and exactly the title of the AAN in a single stage. Eventually, the CyclopusCAD system will be associated with an automaton allowing the preparation of HEp-2 and connected directly with a microscope allowing a fast acquisition and an interpretation of the images and their archiving without any human interference.
CONCLUSION
Assessment of ANA by IIF on HEp-2 cells using the automated interpretation system, the "CyclopusCADImmuno®" is a reliable method for positive/negative differentiation. Continuous integration of IIF images would improve the pattern identification by the CAD.
